Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder
characterized by decreased platelet counts and an increased risk of bleeding. Multiple …

Extraintestinal manifestations of celiac disease (CD) should be considered, even in patients
without typical intestinal symptoms. The aim of our study is to examine the literature …

In cancer patients, thrombocytopenia can result from bone marrow infiltration or from
anticancer medications and represents an important limitation for the use of antithrombotic …

Platelet ageing is an area of research which has gained much interest in recent years.
Newly formed platelets, often referred to as reticulated platelets, young platelets or immature …

Immune thrombocytopenia (ITP) is a rare and orphan disease. The following
recommendations are meant to assist physicians, dentists, and other health-care …

Background Thrombopoietin receptor agonists are frequently used in treating immune
thrombocytopenia (ITP) owing to high response rates and good tolerability. ITP is associated …

Although bleeding is one of the main symptoms of primary immune thrombocytopenia (ITP),
risk factors for bleeding have yet to be fully established. Low platelet count (PC;< 20–30× …

In this review, the recently approved drugs avatrombopag and fostamatinib, which were not
extensively covered within 2019 international recommendations for ITP, will be discussed in …

Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare
syndrome associated with adenoviral vector vaccines for COVID-19. The syndrome is …

Endotheliopathy, according to the “two-activation theory of the endothelium”, can be
triggered by the activated complement system in critical illnesses, such as sepsis and …